1961
DOI: 10.1001/archopht.1961.01840020403014
|View full text |Cite
|
Sign up to set email alerts
|

The Treatment of Ocular Toxoplasmosis with Spiramycin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

1961
1961
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(12 citation statements)
references
References 12 publications
0
12
0
Order By: Relevance
“…Chodos & Habegger-Chodos (1961) showed that in a series of 67 patients spiramycin was an effective agent for use in posterior uveitis presumably caused by toxoplasma. Fajardo, Furguiele & Leopold (1962) reported a series of 87 patients who had received either spiramycin and steroids, sulphadiazine and pyrimethamine and steroids or steroids therapy alone.…”
Section: Clinical Studiesmentioning
confidence: 99%
“…Chodos & Habegger-Chodos (1961) showed that in a series of 67 patients spiramycin was an effective agent for use in posterior uveitis presumably caused by toxoplasma. Fajardo, Furguiele & Leopold (1962) reported a series of 87 patients who had received either spiramycin and steroids, sulphadiazine and pyrimethamine and steroids or steroids therapy alone.…”
Section: Clinical Studiesmentioning
confidence: 99%
“…A broadspectric antibiotic spiramycin which was found in 1954 has a marked effect on the toxoplasmosis at least in animal experiments (Bogacr 1954, Gariit & Eyles 1958 and Bonaduce 1960). On the basis of this Chodos & Habegger- Chodos (1961) experimented with this drug also in human toxoplasmosis with good results -90 per cent of 67 cases were cured. Their conclusion was: nspiramycin administered in a singly dose of 2 g is the therapy of choice in ocular toxoplasmosis.<c…”
Section: Perkinsmentioning
confidence: 96%
“…Long-term treatment with trimethoprim-sulfamethoxazole may prevent recurrences [74]. In pregnant women with newly acquired toxoplasmosis, treatment with spiramycin [75] or azithromycin [76,77] may be used to prevent congenital infection. This is done in concert with the obstetrician, infectious disease specialist and neonatologist, and should be continued until the infant is 1 year of age [78].…”
Section: Toxoplasmosismentioning
confidence: 99%